Sheri Skerget

844 total citations
22 papers, 316 citations indexed

About

Sheri Skerget is a scholar working on Hematology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sheri Skerget has authored 22 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sheri Skerget's work include Multiple Myeloma Research and Treatments (15 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer Genomics and Diagnostics (4 papers). Sheri Skerget is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer Genomics and Diagnostics (4 papers). Sheri Skerget collaborates with scholars based in United States, Netherlands and Spain. Sheri Skerget's co-authors include Timothy L. Karr, Matthew Rosenow, Konstantinos Pétritis, Steve Dorus, Ashoka D. Polpitiya, Deeksha Vishwamitra, Jonathan J. Keats, Raluca Verona, Thomas Renaud and Joseph Mıkhael and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Sheri Skerget

21 papers receiving 315 citations

Peers

Countries citing papers authored by Sheri Skerget

Since Specialization

Citations

This map shows the geographic impact of Sheri Skerget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheri Skerget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheri Skerget more than expected).

Fields of papers citing papers by Sheri Skerget

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheri Skerget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheri Skerget. The network helps show where Sheri Skerget may publish in the future.

Co-authorship network of co-authors of Sheri Skerget

This figure shows the co-authorship network connecting the top 25 collaborators of Sheri Skerget. A scholar is included among the top collaborators of Sheri Skerget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheri Skerget. Sheri Skerget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T-Cell Characteristics Impact Response and Resistance to T-Cell–Redirecting Bispecific Antibodies in Multiple Myeloma 2024 ·Clinical Cancer Research ·Christie P.M. Verkleij, (unknown), Marloes E.C. Broekmans, Kristine A. Frerichs, (unknown), Carolien Duetz, (unknown), S. Rubina Baglio, Sheri Skerget, Rocío Montes de, Sonja Zweegman, Raluca Verona, Tuna Mutis, Niels W.C.J. van de Donk	25
2	Impact of soluble BCMA and non–T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma 2024 ·Blood ·Holly Lee, Michael Durante, Sheri Skerget, Deeksha Vishwamitra, Sacha Benaoudia, Sungwoo Ahn, Mansour Poorebrahim, Elie Barakat, (unknown), Noémie Leblay, Bachisio Ziccheddu, Benjamin Diamond, (unknown), Adam D. Cohen, Ola Landgren, Paola Neri, Francesco Maura, Nizar J. Bahlis	16
3	P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS 2023 ·HemaSphere ·Kristine A. Frerichs, Christie P.M. Verkleij, María‐Victoria Mateos, Sonja Zweegman, (unknown), (unknown), Tom Martin, Cesar Rodriguez, Ajay K. Nooka, (unknown), Sheri Skerget, (unknown), Arnob Banerjee, Katherine Chastain, Alfredo Perales‐Puchalt, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Raluca Verona, Niels W.C.J. van de Donk	2
4	Analysis of infections and parameters of humoral immunity in patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with talquetamab (tal) monotherapy in MonumenTAL-1. 2023 ·Journal of Clinical Oncology ·Paula Rodríguez‐Otero, Carolina Schinke, Ajai Chari, Brea Lipe, Noa Lavi, Leo Rasche, Deeksha Vishwamitra, Sheri Skerget, Raluca Verona, Xuewen Ma, (unknown), Brandi Hilder, Tara Masterson, Michela Campagna, Thomas Renaud, Jaszianne Tolbert, Christoph Heuck, Marie-Anne Damiette Smit, Niels W.C.J. van de Donk	10
5	Updated Results of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma with Prior Exposure to T-Cell Redirecting Therapies: Results of the Phase 1/2 MonumenTAL-1 Study 2023 ·Blood ·Andrzej Jakubowiak, Sébastien Anguille, Lionel Karlin, Ajai Chari, Carolina Schinke, Leo Rasche, Jesús F. San Miguel, Michela Campagna, Brandi Hilder, Tara Masterson, Xiang Qin, Thomas Renaud, Jaszianne Tolbert, Deeksha Vishwamitra, Sheri Skerget, Philippe Moreau	31
6	POSTER: MM-191 Analysis of Infections and Parameters of Humoral Immunity in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With Talquetamab (tal) Monotherapy in MonumenTAL-1 2023 ·Clinical Lymphoma Myeloma & Leukemia ·Paula Rodríguez‐Otero, Carolina Schinke, Ajai Chari, Brea Lipe, Noa Lavi, Leo Rasche, Deeksha Vishwamitra, Sheri Skerget, Raluca Verona, Xuewen Ma, (unknown), Brandi Hilder, Tara Masterson, Michela Campagna, Thomas Renaud, Jaszianne Tolbert, Christoph Heuck, (unknown), Niels W.C.J. van de Donk	0
7	P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMUNITY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH TALQUETAMAB (TAL) MONOTHERAPY IN MONUMENTAL-1 2023 ·HemaSphere ·Leo Rasche, Carolina Schinke, Ajai Chari, Brea Lipe, Noa Lavi, Paula Rodríguez‐Otero, Deeksha Vishwamitra, Sheri Skerget, Raluca Verona, Xuewen Ma, (unknown), Brandi Hilder, Tara Masterson, Michela Campagna, Thomas Renaud, Jaszianne Tolbert, Christoph Heuck, (unknown), Niels W.C.J. van de Donk	3
8	Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment 2021 ·Leukemia Research ·Krisstina Gowin, Sheri Skerget, Jonathan J. Keats, Joseph Mıkhael, Andrew J. Cowan	16
9	High-Risk Gene Expression Subtype Provides Molecular Basis for Different Clinical Presentation of Primary and Secondary Plasma Cell Leukemia 2021 ·Blood ·Sheri Skerget, (unknown), Joseph Mıkhael, Jonathan J. Keats	1
10	Multiple Myeloma Epigenetic Programming Prognostic of Outcome Converges with Loci Reprogrammed in Relapsed/Refractory Disease 2019 ·Blood ·Benjamin G. Barwick, Sheri Skerget, Jonathan J. Keats, Daniel Auclair, Sagar Lonial, Lawrence Boise, Paula M. Vertino, Doris R. Powell	1
11	Unsupervised Clustering of DNA Copy Number Profiles Identifies a High-Risk Subtype of Hyperdiploid Multiple Myeloma: An Mmrf Commpass Analysis 2019 ·Blood ·(unknown), Sheri Skerget, Jessica Aldrich, Christophe Legendre, Sara Nasser, (unknown), Daniel Auclair, (unknown), Sagar Lonial, Jonathan J. Keats	2
12	Molecular Characterization of Bone Marrow and Peripheral Blood Compartments from Patients with Plasma Cell Leukemia in the Mmrf Commpass Study 2019 ·Blood ·Sheri Skerget, (unknown), Sara Nasser, Christophe Legendre, (unknown), (unknown), Daniel Auclair, Sagar Lonial, Jonathan J. Keats	1
13	Abstract 839: Whole genome DNA methylation analysis of multiple myeloma identifies pervasive hypomethylation and biomarkers of survival 2019 ·Cancer Research ·Benjamin G. Barwick, Doris R. Powell, (unknown), Sheri Skerget, Jonathan J. Keats, Daniel Auclair, Sagar Lonial, Lawrence Boise, Paula M. Vertino	3
14	Identification and Molecular Characterization of High-Risk Multiple Myeloma Patients from the MMRF CoMMpass Study at Diagnosis and Progression 2019 ·Clinical Lymphoma Myeloma & Leukemia ·Sheri Skerget, (unknown), Sara Nasser, Christophe Legendre, (unknown), Daniel Auclair, Sagar Lonial, Jonathan J. Keats	1
15	Identification and characterization of the zebra finch (Taeniopygia guttata) sperm proteome 2018 ·Journal of Proteomics ·Melissah Rowe, Sheri Skerget, Matthew Rosenow, Timothy L. Karr	9
16	Analysis of Sequential Patient Samples from the Mmrf Commpass Study Identifies a High Risk Progression Phenotype 2018 ·Blood ·Sheri Skerget, (unknown), Jessica Aldrich, Sara Nasser, (unknown), Christophe Legendre, (unknown), Lori Cuyugan, Jonathan Adkins, Erica E. Tassone, (unknown), Daniel Auclair, Winnie S. Liang, Sagar Lonial, Jonathan J. Keats	2
17	A Molecular Analysis of Cereblon-Related Immunomodulatory Drug Resistance in Commpass Multiple Myeloma Patients 2017 ·Blood ·Sheri Skerget, (unknown), (unknown), Christophe Legendre, Jessica Aldrich, Sara Nasser, (unknown), Daniel Auclair, Winnie S. Liang, Sagar Lonial, Jonathan J. Keats	2
18	Sperm Proteome Maturation in the Mouse Epididymis 2015 ·PLoS ONE ·Sheri Skerget, Matthew Rosenow, Konstantinos Pétritis, Timothy L. Karr	90
19	The Rhesus Macaque (Macaca mulatta) Sperm Proteome 2013 ·Molecular & Cellular Proteomics ·Sheri Skerget, Matthew Rosenow, Ashoka D. Polpitiya, Konstantinos Pétritis, Steve Dorus, Timothy L. Karr	44
20	Proteomic discovery of diverse immunity molecules in mammalian spermatozoa 2012 ·Systems Biology in Reproductive Medicine ·Steve Dorus, Sheri Skerget, Timothy L. Karr	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact